duplex ON7:ON9 (Series B) bearing only one triaza crown
ether unit X (Tm = 41.0 °C). Different trends with respect to the
dependence of the thermal stabilities on ligand chain length and
ligand concentration for Series A, B and C were observed as
depicted in Table 1 (DTm values are calculated relative to the Tm
value recorded for each series in the absence of a ligand).
For duplex Series A involving duplexes with two juxtaposi-
tioned crown ether units X, optimal complexation of an
alkanediamine ligand should be for one equivalent of ligand of
the appropriate length allowing complexation-driven reversible
end-joining of the two strands of the duplex with concomitant
increased thermal stabilities. For duplex Series B, complexation
of the alkanediamine ligands was expected not to strongly
influence the thermal stability and no difference between the
different ligands and ligand concentrations was expected. In
Series A, all ligands induced an increase in Tm by 1.5–3.5 °C
except for the shortest ligand 12, and, in general, similar results
were obtained for Series B. Overall, no strong effect of the
equivalents of ligand present on the obtained DTm values was
observed
The results obtained in Series C are in strong contrast to those
obtained in Series A and B and therefore support specific
complexation of the alkanediamine ligands with the crown ether
unit(s) in Series A and B. Interstrand cross complexation
involving either the two juxtapositioned crown ether units in
Series A (e.g., with 1 eq. of ligands 13 and 14) or one crown
ether unit and the phosphate backbone (in Series A and B)
would explain the affinity enhancing effects observed. The
comparable results obtained with one and ten equivalents of
ligands render any conclusion regarding the actual mode of
complexation impossible at this stage.
Oligonucleotide crown ether conjugates have been in-
troduced herein as a novel class of potentially very useful
molecular building blocks for construction of self-assembling
molecular receptors. We are currently studying conformation-
ally restricted variants of the systems introduced herein and
synthesizing 15N-labelled crowns and ligands for NMR struc-
tural studies.
We thank the Nucleic Acid Center, The Danish Research
Agency and the Deutsche Forschungsgemeinschaft for financial
support and Ms Britta M. Dahl for oligonucleotide synthesis.
Fig. 1 Sequences synthesized, the structure of LNA nucleotide monomers
(TL and MeCL are LNA thymin-1-yl and LNA 5-methylcytosin-1-yl
monomers, respectively) and a representation of the putative mode of
complexation of a alkanediamine ligand by the two triaza crown ether units
in the oligonucleotide duplex ON7:ON8; only four base pairs are shown in
the structural model in which the dotted lines indicate probable hydrogen
bonds between the triaza crown ether units and ligand 14. Alkanediamine
ligands used: H2N(CH2)nNH2; n = 6 (12), n = 8 (13), n = 10 (14) and n
= 12 (15).
Notes and references
‡ Amidite 6: 31P NMR data: d (CH3CN) 148.5 ppm; MALDI-MS ([M +
Na]+ m/z 708.4224; calcd. 708.4229.
§ We have defined LNA as an oligonucleotide containing one or more
conformationally locked 2A-O,4A-C-methylene-b-
D-ribofuranosyl nucleo-
Table 1 Thermal denaturation experiments in the presence of alkanedia-
mine ligands 12–15a
tide monomer(s) (“LNA monomer(s)”).
¶ MALDI-MS m/z for ON7: [M 2 H]2 3327; calcd. 3325; [M 2 2H + Na]2
3349; calcd. 3347; MALDI-MS m/z for ON8: [M 2 H]2 3299; calcd. 3298;
[M 2 2H + Na]2 3322; calcd. 3320.
Duplex series
Eq.
Tm/°C
DTm/°C
∑ This duplex was available and chosen as reference because of close
resemblance to the ON7:ON8 and ON7:ON9 duplexes with respect to
sequence, composition and structure (see ref. 13 and ref. 14 for relevant
NMR structural work).
Series A (ON7:ON8)
Ligand 12
Ligand 13
Ligand 14
Ligand 15
Series B (ON7:ON9)
Ligand 12
Ligand 13
Ligand 14
Ligand 15
Series C (ON10:ON11)
Ligand 12
Ligand 13
Ligand 14
Ligand 15
42.5
1/10
1/10
1/10
1/10
42.0/42.0
45.0/44.0
46.0/45.0
44.5/45.0
41.0
40.0/44.5
43.5/43.5
43.5/42.0
44.5/43.5
43.5
20.5/20.5
+2.5/+1.5
+3.5/+2.5
+2.0/+2.5
1 H. J. Buschmann, L. Mutihac and K. Jansen, J. Incl. Phenom., 2001, 39,
1.
1/10
1/10
1/10
1/10
21.0/+3.5
+2.5/+2.5
+2.5/+1.0
+3.5/+2.5
2 X. Wu and S. Pitsch, Nucleic Acids Res., 1998, 26, 4315.
3 C. J. Pedersen and H. K. Frensdorff, Angew. Chem., 1972, 84, 16.
4 D. J. Cram and J. M. Lehn, Acc. Chem. Res., 1978, 11, 8.
5 R. M. Izatt, R. E. Terry, B. L. Haymore, L. D. Hansen, N. K. Dalley, A.
G. Avondet and J. J. Christensen, J. Am. Chem. Soc., 1976, 98, 7620.
6 J. M. Lehn, Tetrahedron Lett., 1980, 21, 1323.
7 K. E. Krakowiak, J. S. Bradshaw, R. M. Izatt and D. J. Zamecka-
Krakowiak, J. Org. Chem., 1989, 54, 4061.
8 S. K. Singh, P. Nielsen, A. A. Koshkin and J. Wengel, Chem. Commun.,
1998, 455.
9 A. A. Koshkin, S. K. Singh, P. Nielsen, V. K. Rajwanshi, R. Kumar, M.
Meldgaard, C. E. Olsen and J. Wengel, Tetrahedron, 1998, 54, 3607.
10 S. Obika, D. Nanbu, Y. Hari, J. Andoh, K. Morio, T. Doi and T.
Imanishi, Tetrahedron Lett., 1998, 39, 5401.
11 M. H. Caruthers, Acc. Chem. Res., 1991, 24, 278.
12 V. K. Rajwanshi, A. E. Håkannson, B. M. Dahl and J. Wengel, Chem.
Commun., 1999, 1395.
13 G. A. Jensen, S. K. Singh, R. Kumar, J. Wengel and J. P. Jacobsen, J.
Chem. Soc., Perkin Trans. 2, 2001, 1224.
14 K. E. Nielsen, S. K. Singh, J. Wengel and J. P. Jacobsen, Bioconjugate
Chem., 2000, 11, 228.
1/10
1/10
1/10
1/10
42.5/42.5
42.0/42.5
42.5/42.0
41.5/41.5
21.0/21.0
21.5/21.0
21.0/21.5
22.0/22.0
a Melting temperatures [Tm values (DTm values are calculated relative to the
Tm value recorded in the absence of a ligand)] measured as the maximum of
the first derivative of the melting curve (A260 vs. temperature; 10 °C to 80
°C with an increase of 1 °C min21) recorded in medium salt buffer (10 mM
sodium phosphate, 100 mM sodium chloride, 0.02 mM EDTA, pH 7.0)
using 1 µM concentrations of the two complementary strands. Hyper-
chromicity values and transition intervals were similar for all melting
curves. Each Tm value was determined in two independent experiments and
DTm values were within ±0.5 °C consistent for the two experiments. “Eq.”
denotes the molar equivalent(s) of ligand used relative to duplex. See
caption of Fig. 1 for structures of alkanediamine ligands 12–15.
CHEM. COMMUN., 2003, 1006–1007
1007